Eric R. A. Vos

854 total citations
22 papers, 284 citations indexed

About

Eric R. A. Vos is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Eric R. A. Vos has authored 22 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 7 papers in Modeling and Simulation. Recurrent topics in Eric R. A. Vos's work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 epidemiological studies (7 papers) and COVID-19 Clinical Research Studies (6 papers). Eric R. A. Vos is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 epidemiological studies (7 papers) and COVID-19 Clinical Research Studies (6 papers). Eric R. A. Vos collaborates with scholars based in Netherlands, United Kingdom and Malaysia. Eric R. A. Vos's co-authors include Liesbeth Mollema, Fiona van der Klis, Hester E. de Melker, Jeffrey van Vliet, Jantien A. Backer, Janneke D. M. Verberk, Gerco den Hartog, Hester E. de Melker, Jacco Wallinga and Don Klinkenberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Eric R. A. Vos

21 papers receiving 281 citations

Peers

Eric R. A. Vos
Brooke Bregman United States
Hester Allen United Kingdom
Cuc H. Tran United States
Meredith Haddix United States
Rebekah H. Borse United States
Brooke Bregman United States
Eric R. A. Vos
Citations per year, relative to Eric R. A. Vos Eric R. A. Vos (= 1×) peers Brooke Bregman

Countries citing papers authored by Eric R. A. Vos

Since Specialization
Citations

This map shows the geographic impact of Eric R. A. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric R. A. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric R. A. Vos more than expected).

Fields of papers citing papers by Eric R. A. Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric R. A. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric R. A. Vos. The network helps show where Eric R. A. Vos may publish in the future.

Co-authorship network of co-authors of Eric R. A. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Eric R. A. Vos. A scholar is included among the top collaborators of Eric R. A. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric R. A. Vos. Eric R. A. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vos, Eric R. A., Stijn P. Andeweg, Gerco den Hartog, et al.. (2025). Using SARS-CoV-2 nucleoprotein antibodies to detect (re)infection. Epidemiology and Infection. 153. e38–e38. 1 indexed citations
2.
Vos, Eric R. A., Gaby Smits, Marjan Kuijer, et al.. (2024). SARS‐CoV‐2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era: Input for Future Response. Influenza and Other Respiratory Viruses. 18(6). e13312–e13312. 4 indexed citations
3.
Melker, Hester E. de, Eric R. A. Vos, Janneke van de Wijgert, et al.. (2024). Health-related quality of life during the COVID-19 pandemic: The impact of restrictive measures using data from two Dutch population-based cohort studies. PLoS ONE. 19(3). e0300324–e0300324.
4.
Verheul, Marije K., Joanna Kaczorowska, Marloes I. Hofstee, et al.. (2024). Protective mucosal SARS-CoV-2 antibodies in the majority of the general population in the Netherlands. Mucosal Immunology. 17(4). 554–564. 4 indexed citations
5.
Backer, Jantien A., Eric R. A. Vos, Gerco den Hartog, et al.. (2024). Contact behaviour before, during and after the COVID-19 pandemic in the Netherlands: evidence from contact surveys, 2016 to 2017 and 2020 to 2023. Eurosurveillance. 29(43). 3 indexed citations
6.
Boer, Pieter T. de, Jan van de Kassteele, Eric R. A. Vos, et al.. (2023). Age‐specific severity of severe acute respiratory syndrome coronavirus 2 in February 2020 to June 2021 in the Netherlands. Influenza and Other Respiratory Viruses. 17(8). e13174–e13174. 7 indexed citations
7.
Backer, Jantien A., Philippe Beutels, Pietro Coletti, et al.. (2023). Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands. Scientific Reports. 13(1). 5166–5166. 12 indexed citations
8.
Hoogen, Lotus L. van den, Marije K. Verheul, Eric R. A. Vos, et al.. (2022). SARS-CoV-2 Spike S1-specific IgG kinetic profiles following mRNA or vector-based vaccination in the general Dutch population show distinct kinetics. Scientific Reports. 12(1). 5935–5935. 15 indexed citations
9.
Vos, Eric R. A., Michiel van Boven, Gerco den Hartog, et al.. (2021). Associations Between Measures of Social Distancing and Severe Acute Respiratory Syndrome Coronavirus 2 Seropositivity: A Nationwide Population-based Study in the Netherlands. Clinical Infectious Diseases. 73(12). 2318–2321. 25 indexed citations
10.
Vos, Eric R. A., Jeffrey van Vliet, Gerco den Hartog, et al.. (2021). Circulation of Bordetella pertussis in the Caribbean Netherlands: a population-based seroepidemiological study. International Journal of Infectious Diseases. 111. 21–27. 1 indexed citations
11.
Backer, Jantien A., Liesbeth Mollema, Eric R. A. Vos, et al.. (2021). Impact of physical distancing measures against COVID-19 on contacts and mixing patterns: repeated cross-sectional surveys, the Netherlands, 2016–17, April 2020 and June 2020. Eurosurveillance. 26(8). 56 indexed citations
12.
McDonald, Scott, Fuminari Miura, Eric R. A. Vos, et al.. (2021). Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands. European Journal of Epidemiology. 36(7). 735–739. 11 indexed citations
13.
Ong, David S. Y., et al.. (2021). Trends in SARS-CoV-2 seroprevalence amongst urban paediatric patients compared with a nationwide cohort in the Netherlands. SHILAP Revista de lepidopterología. 1(4). 100045–100045. 1 indexed citations
14.
Knol, Mirjam J., Eric R. A. Vos, Elisabeth A. M. Sanders, et al.. (2021). Seroprevalence of meningococcal ACWY antibodies across the population in the Netherlands: Two consecutive surveys in 2016/17 and 2020. Vaccine. 40(1). 59–66. 1 indexed citations
15.
Vos, Eric R. A., Liesbeth Mollema, Michiel van Boven, et al.. (2020). High varicella zoster virus susceptibility in Caribbean island populations: Implications for vaccination. International Journal of Infectious Diseases. 94. 16–24. 5 indexed citations
17.
Vos, Eric R. A., Gerco den Hartog, Rutger M. Schepp, et al.. (2020). Nationwide seroprevalence of SARS-CoV-2 and identification of risk factors in the general population of the Netherlands during the first epidemic wave. Journal of Epidemiology & Community Health. 75(6). 489–495. 60 indexed citations
18.
Verberk, Janneke D. M., et al.. (2019). Third national biobank for population-based seroprevalence studies in the Netherlands, including the Caribbean Netherlands. BMC Infectious Diseases. 19(1). 470–470. 45 indexed citations
19.
Vos, Eric R. A., Liesbeth Mollema, Rob van Binnendijk, et al.. (2019). Seroepidemiology of Measles, Mumps and Rubella on Bonaire, St. Eustatius and Saba: The First Population-Based Serosurveillance Study in Caribbean Netherlands. Vaccines. 7(4). 137–137. 5 indexed citations
20.
Alberts, Catharina J., Eric R. A. Vos, Hanneke Borgdorff, et al.. (2016). Vaginal high-risk human papillomavirus infection in a cross-sectional study among women of six different ethnicities in Amsterdam, the Netherlands: the HELIUS study. Sexually Transmitted Infections. 92(8). 611–618. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026